Table 3.
Characteristics of participants with the rs8099917 TT and GT/GG genotypes among those with available genotype testing.
Characteristic | Overall (n=102) | GG/GT (n=39) | % | TT (n=63) | % |
---|---|---|---|---|---|
Sex | |||||
Male | 74 | 29 | 74% | 45 | 71% |
Female | 28 | 10 | 26% | 18 | 29% |
Ethnicity | |||||
Caucasian | 92 | 34 | 87% | 58 | 92% |
Other | 10 | 5 | 13% | 5 | 8% |
Presentation of recent HCV | |||||
Asymptomatic seroconversion | 55 | 27 | 69% | 28 | 44% |
Acute clinical (no jaundice) | 23 | 9 | 23% | 14 | 22% |
Acute clinical (with jaundice) | 22 | 2 | 5% | 20 | 32% |
Peak ALT prior to enrolment (IU/L) | |||||
≤ 400 | 37 | 21 | 54% | 16 | 25% |
> 400 | 60 | 15 | 38% | 45 | 71% |